
Professor Ian Frazer AC

At Microba Life Sciences, we analyse the microbiome to help the world understand disease, develop new diagnostic tools and discover novel therapeutics.
We are determined to be the research powerhouse behind new advancements using the gut microbiome and we will achieve this by continually increasing and refining the precision of our analysis to discover ever-deeper insights into the relationships between gut microorganisms and health.
We believe in working together with international partners to fast track these new advances. The potential is too big for one company to do it alone so it is important that we find partners who share our passion and our scientific rigour.
In short, we believe in transforming human health over the coming decades through a continual evolution in diagnosing and treating, based on ever more precise analysis of the microbiome.